News Roundup / UK Pharma May 2020
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British…
Oxford BioMedica
Last updated: 13.02.2014
Address: Medawar Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford, OX4 4GA,United Kingdom
Tel: +44 (0) 1865 783 000
Web: http://www.oxfordbiomedica.co.uk/
Company description
Oxford BioMedica has established a platform of technologies in gene delivery and immunotherapy, protected by an extensive intellectual property estate. Through in-house and collaborative development, the Company has a broad pipeline of gene-based product candidates for the treatment of age-related or inherited neurodegenerative and ocular diseases. In addition, Oxford BioMedica and its collaborators are developing novel targeted therapies and therapeutic vaccines to treat multiple types of cancer.
Products and services
Oxford BioMedica’s two lead programmes are a gene therapy for Parkinson’s disease (ProSavin®) in Phase I/II development and a therapeutic cancer vaccine (TroVax®) in Phase II development.
The other products include RetinoStat®, StarGen™, UshStat™, EncorStat™, MoNuDin®, Hi-8® MEL, MetXia®, EndoAngio-GT and Targeted Antibody Therapy.
Related
Coronavirus / GSK & Sanofi’s Unprecedented COVID-19 Vaccine Collaboration
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
The UK / The G7’s Hottest Life Science Investment Destination?
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is…
Brexit / Uncertainty Still Reigns for UK Life Sciences
Friday January 31 2020 was officially dubbed “Brexit Day” as the UK finally left the EU, following British…
Biotech Funding / 2019 A Boom Year for UK Biotech, Despite Brexit Concerns
Although biotech financing in the UK took a hit last year in large part thanks to uncertainty around Brexit, 2019…
Cannabis / GW Pharma's CBD Drug Profits Soar in 2nd Quarter 2019
GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019,…
Amryt: A Rare Disease Startup Going Global
Formed in 2015, listed UK start-up Amryt targets rare diseases with high unmet medical need. With one commercial…
HIV ‘Cure’ on the Horizon? London Patient Cleared of AIDS Virus
Hopes have been raised of a cure for AIDS after a patient in London became free of the HIV virus following a bone…
Profile / CBD Pioneers GW Pharmaceuticals
Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company…
The European Medicines Verification System Launches to Tackle Fake Drugs
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…
The UK to Incentivise Big Pharma Firms to Develop New Antibiotics
In recent years, apocalyptic conversations around superbugs caused by antimicrobial resistance (AMR) have been on…
The 5 Most Influential Medical Research Charities in the UK
An unusual characteristic of the UK’s healthcare landscape is that charities fund the vast majority of…
